REDHILL BIOPHARMA LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 12243
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901638 Composition and method for treating an autoimmune diseaseSep 19, 12Feb 27, 18[A61K]
9844540 Combination therapies for treating cancerOct 06, 16Dec 19, 17[A61K, A01N]
9675588 Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptomsMar 11, 15Jun 13, 17[A61K, A61P]
9636305 Antiemetic extended release solid dosage formsMar 14, 14May 02, 17[A61K]
9603806 English Title Not AvailableApr 21, 16Mar 28, 17[A61K]
9498445 English Title Not AvailableOct 24, 14Nov 22, 16[A61K]
9314477 Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereofMay 07, 14Apr 19, 16[A61K, A61P]
9198926 Methods and compositions comprising rifabutin, clarithromycin, and clofazimineMay 07, 14Dec 01, 15[A61K, A61P]
9072763 Methods and compositions for treating inflammatory bowel diseaseDec 20, 12Jul 07, 15[A61K, A61P]
9050263 English Title Not AvailableFeb 12, 14Jun 09, 15[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0228,464 COMPOSITIONS COMPRISING RIFABUTIN, CLARITHROMYCIN, AND CLOFAZIMINE AND USES THEREOFAbandonedApr 18, 16Aug 11, 16[A61K]
2014/0271,851 ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMSAbandonedMar 14, 14Sep 18, 14[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.